Northwest Biotherapeutics CTO to present DCVax-L survival analysis at 2026 BNOS meeting
Dr. Marnix Bosch is scheduled to speak on July 3 at 10:00 a.m. GMT on propensity score matching analyses of DCVax-L and patient survival, with slides to be posted afterward.